https://menafn.com/1110691427/Olema-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). SAN FRANCISCO, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc....
oncology reportsolemainducementgrantsnasdaq
https://www.biospace.com/press-releases/alx-oncology-reports-aspen-03-and-aspen-04-phase-2-trials-evaluating-evorpacept-with-a-checkpoint-inhibitor-for-the-treatment-of-head-and-neck-cancers-did-not-meet-primary-endpoints
oncology reportsalxaspenphase
https://www.barchart.com/story/news/34144598/predictive-oncology-reports-second-quarter-2025-financial-results-and-provides-corporate-update
PITTSBURGH, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology (Nasdaq: POAI) , a science-driven company leveraging its proprietary artificial intelligence...
oncology reportssecond quarterpredictivefinancialresults
https://www.prnewswire.com/news-releases/citius-oncology-inc-reports-fiscal-year-2025-financial-results-and-provides-business-update-302648892.html
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc....
fiscal yearoncologyincreportsfinancial